Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Anergen claims production methods for AnergiX compounds

Aug. 25, 1998

Phytera and Tsumura Juntendo expand research collaboration

Aug. 24, 1998

International team identifies selective P2X antagonists

Aug. 21, 1998

MorphoSys and Pharmacia & Upjohn suspend joint research program

Aug. 20, 1998

Genzyme division and Bayer enter into genomics agreement

Aug. 20, 1998

Genome Therapeutics and Cadus join forces in the search for new therapeutic targets

Aug. 19, 1998

Matrix granted Japanese patent; U.S. patent reissued

Aug. 18, 1998

MorphoSys and DuPont Pharmaceuticals sign collaboration agreement

Aug. 14, 1998

Fusion protein enables large-scale production of bioactive carbohydrates

Aug. 14, 1998

Idun to license patent application for apoptosis model

Aug. 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...